About 50% of women have dense breast tissue. Mammography sensitivity decreases with higher breast density because both cancer and dense breast tissue appear white on mammograms.³
With a cancer diagnosis, early detection means better outcomes. It means hope. But when it comes to breast cancer, a significant portion of women have reduced opportunity for an early, life-saving diagnosis.
You know that one out of eight women will develop breast cancer in her lifetime.¹ That’s why you take charge of your breast health: you monitor your breasts and maintain a healthy lifestyle. You also know that regular screening is a key part of maintaining breast health.
What you may not know is that for some women, screening by mammograms alone may not be enough.² ³
For many women, for many reasons, early breast cancer detection through existing screening protocols is reduced.
About half of all women have dense or very dense breasts.
Mammography sensitivity decreases with higher breast density because both cancer and dense breast tissue appear white on mammograms, creating a camouflage effect.²
In Canada, women under 50-years aren’t typically referred for mammography screening. Breast cancer among younger women is less common but still significant. In fact, 18 percent of breast cancer diagnoses are women under age 50.³
About 50% of women have dense breast tissue. Mammography sensitivity decreases with higher breast density because both cancer and dense breast tissue appear white on mammograms.³
For many women, for many reasons, the odds of early breast cancer detection through existing screening protocols are reduced.²
About half of all women have dense or very dense breasts.
Mammography sensitivity decreases with higher breast density because both cancer and dense breast tissue appear white on mammograms, creating a camouflage effect.⁴
In Canada, women under 50 aren’t typically referred for mammography screening. Breast cancer among younger women is less common, but still significant. In fact, 17 percent of breast cancer diagnoses are women under 50.⁵
Mammography sensitivity decreases for women with higher breast density because both cancer and dense breast tissue appear white on mammograms, creating a camouflage effect.³ That means the odds of early detection are reduced.
A different approach to detection
Syantra DX™ Breast Cancer is a blood test for breast cancer screening. It’s an easy, convenient, and accurate tool that supports womens’ access to early detection.
How does the test work?
Syantra DX™ Breast Cancer is a precision medicine tool that measures a panel of gene expression biomarkers from whole blood. It then uses a software package, developed with machine learning, to interpret data. It provides a molecular approach to breast cancer screening that can detect invasive disease at early stages.
Monitoring your breast health starts with a routine blood draw
Syantra DX™ Breast Cancer is a blood-based diagnostic. Patients simply go for a routine blood collection and then meet with their physician to discuss their test results once they’re ready.
Interested in learning more about Syantra DX™ Breast Cancer or Syantra Inc.? Contact us through the form below.
Syantra DX™ Breast Cancer is a screening test and may be used as part of the regular screening process. There is the potential for false negative and false positive results to occur. All results should be interpreted by a qualified healthcare provider, and no interventional action should be taken based solely on Syantra DX™ Breast Cancer results.
2023 | Syantra Inc. | 1-877-331-0516
We value your privacy.
Read about it here
Website and branding by:
IVY Design Inc.
We